|
and Colitis-Associated Colon Cancer
|
|||
| |||||||||||||||||||||||||||||||||||||||||
and Colitis-Associated Colon Cancer . In the first sentence of the fourth paragraph (page 2733), etanercept should have been described as "a human TNF-
antagonist (a fusion protein of the ligand-binding portion of the human p75 TNF receptor with the Fc portion of human IgG1)" rather than as "a monoclonal antibody that binds TNF-
." The article has been corrected on the Journal's Web site at www.nejm.org.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |